<bill session="116" type="h" number="8168" updated="2023-01-11T13:45:02Z">
  <state datetime="2020-09-04">REFERRED</state>
  <status>
    <introduced datetime="2020-09-04"/>
  </status>
  <introduced datetime="2020-09-04"/>
  <titles>
    <title type="display">Science in Blood Donation Act of 2020</title>
    <title type="short" as="introduced">Science in Blood Donation Act of 2020</title>
    <title type="official" as="introduced">To require the guidance of the Food and Drug Administration on reducing the risk of human immunodeficiency virus (HIV), hepatitis A, and hepatitis B transmission by blood and blood products (including the donor history questionnaire) to be based on an individual risk assessment of sexual behaviors upon which all donors are evaluated equally, without regard to sexual orientation or gender identity, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="D000627"/>
  <cosponsors>
    <cosponsor bioguide_id="G000587" joined="2020-10-23"/>
    <cosponsor bioguide_id="H000324" joined="2020-09-24"/>
    <cosponsor bioguide_id="H001038" joined="2020-09-11"/>
    <cosponsor bioguide_id="L000586" joined="2020-10-09"/>
    <cosponsor bioguide_id="M001160" joined="2020-09-11"/>
    <cosponsor bioguide_id="N000179" joined="2020-10-02"/>
    <cosponsor bioguide_id="N000147" joined="2020-09-11"/>
    <cosponsor bioguide_id="O000172" joined="2020-10-23"/>
    <cosponsor bioguide_id="P000597" joined="2020-10-02"/>
    <cosponsor bioguide_id="Q000023" joined="2020-09-04"/>
    <cosponsor bioguide_id="S001204" joined="2020-09-11"/>
    <cosponsor bioguide_id="S001205" joined="2020-09-11"/>
    <cosponsor bioguide_id="S001200" joined="2020-09-11"/>
    <cosponsor bioguide_id="T000193" joined="2020-09-24"/>
    <cosponsor bioguide_id="W000822" joined="2020-10-09"/>
    <cosponsor bioguide_id="W000826" joined="2020-09-24"/>
  </cosponsors>
  <actions>
    <action datetime="2020-09-04">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-09-04" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Congressional oversight"/>
    <term name="Disability and health-based discrimination"/>
    <term name="Government information and archives"/>
    <term name="HIV/AIDS"/>
    <term name="Health information and medical records"/>
    <term name="Health promotion and preventive care"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Sex, gender, sexual orientation discrimination"/>
    <term name="Sexually transmitted diseases"/>
  </subjects>
  <amendments/>
  <summary date="2021-04-14T19:44:20Z" status="Introduced in House">Science in Blood Donation Act of 2020

This bill requires the Food and Drug Administration (FDA) to revise its guidance on reducing the risk of transmitting by blood transfusion human immunodeficiency virus, hepatitis A, and hepatitis B.

Specifically, the FDA shall update its guidance to remove recommendations to not receive blood donations from a man who had sex with another man in the past three months. The FDA shall also remove recommendations to not receive blood donations from a woman who in the last three months had sex with such a man.

The FDA's updated guidance shall be based on an individual risk assessment of sexual behaviors that evaluate all donors equally without regard to sexual orientation or gender identity.</summary>
</bill>
